Incident heart failure and recurrent coronary events following acute myocardial infarction

IF 45.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS European Heart Journal Pub Date : 2025-01-28 DOI:10.1093/eurheartj/ehae885
Javed Butler, Kendall Hammonds, Khawaja M Talha, Ayman Alhamdow, Monica M Bennett, J Vee Anne Bomar, Jason A Ettlinger, Monica Martinez Traba, Elisa L Priest, Niklas Schmedt, Cecilia Zeballos, Courtney N Shaver, Aasim Afzal, Robert J Widmer, Robert L Gottlieb, Michael J Mack, Milton Packer
{"title":"Incident heart failure and recurrent coronary events following acute myocardial infarction","authors":"Javed Butler, Kendall Hammonds, Khawaja M Talha, Ayman Alhamdow, Monica M Bennett, J Vee Anne Bomar, Jason A Ettlinger, Monica Martinez Traba, Elisa L Priest, Niklas Schmedt, Cecilia Zeballos, Courtney N Shaver, Aasim Afzal, Robert J Widmer, Robert L Gottlieb, Michael J Mack, Milton Packer","doi":"10.1093/eurheartj/ehae885","DOIUrl":null,"url":null,"abstract":"Background and Aims Recurrent myocardial infarction (MI) and incident heart failure (HF) are major post-MI complications. Herein, contemporary post-MI risks for recurrent MI and HF are described. Methods A total of 6804 patients with a primary discharge diagnosis of MI at 28 Baylor Scott & White Health hospitals (January 2015 to December 2021) were studied. Patient characteristics, treatment, and outcomes, including incident HF, recurrent MI, all-cause death, and all-cause and cardiovascular rehospitalizations, were assessed. Landmark approach anchored at 3 months post-discharge was used to assess 1-year outcomes. Results Median age was 69 years, 59.7% were male, and 76.7% had non-ST-elevation MI. Comorbidities included hypertension (89%), dyslipidaemia (87%), Type 2 diabetes (48%), and chronic kidney disease (34%); 17% had a history of MI and 23% of HF; 63% underwent percutaneous/surgical revascularization. In landmark-anchored 1-year outcomes (N = 6210), 413 (6.7%) patients died, 1730 (27.9%) had all-cause and 735 (11.8%) cardiovascular hospitalizations, 234 (3.8%) had recurrent MI. Of patients without history of HF, 1160 (23.8%) developed incident HF [42.2%, 26.7%, and 31.1% with ejection fraction (EF) < 40%, 41–49%, and >50%, respectively) within 3 months of discharge. Patients who developed HF had higher risk of death and hospitalizations (all P < .001), irrespective of EF. Of 2179 patients with EF > 50% without prevalent HF or HF during index hospitalization, 257 (11.8%) developed HF and 77 (3.5%) recurrent MI within 1 year. Conclusions In a contemporary post-MI cohort, the risk for incident HF was greater than recurrent MI, even among those with normal EF and no HF at discharge.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"25 1","pages":""},"PeriodicalIF":45.3000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurheartj/ehae885","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Aims Recurrent myocardial infarction (MI) and incident heart failure (HF) are major post-MI complications. Herein, contemporary post-MI risks for recurrent MI and HF are described. Methods A total of 6804 patients with a primary discharge diagnosis of MI at 28 Baylor Scott & White Health hospitals (January 2015 to December 2021) were studied. Patient characteristics, treatment, and outcomes, including incident HF, recurrent MI, all-cause death, and all-cause and cardiovascular rehospitalizations, were assessed. Landmark approach anchored at 3 months post-discharge was used to assess 1-year outcomes. Results Median age was 69 years, 59.7% were male, and 76.7% had non-ST-elevation MI. Comorbidities included hypertension (89%), dyslipidaemia (87%), Type 2 diabetes (48%), and chronic kidney disease (34%); 17% had a history of MI and 23% of HF; 63% underwent percutaneous/surgical revascularization. In landmark-anchored 1-year outcomes (N = 6210), 413 (6.7%) patients died, 1730 (27.9%) had all-cause and 735 (11.8%) cardiovascular hospitalizations, 234 (3.8%) had recurrent MI. Of patients without history of HF, 1160 (23.8%) developed incident HF [42.2%, 26.7%, and 31.1% with ejection fraction (EF) < 40%, 41–49%, and >50%, respectively) within 3 months of discharge. Patients who developed HF had higher risk of death and hospitalizations (all P < .001), irrespective of EF. Of 2179 patients with EF > 50% without prevalent HF or HF during index hospitalization, 257 (11.8%) developed HF and 77 (3.5%) recurrent MI within 1 year. Conclusions In a contemporary post-MI cohort, the risk for incident HF was greater than recurrent MI, even among those with normal EF and no HF at discharge.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
急性心肌梗死后的心力衰竭和复发性冠状动脉事件
背景和目的复发性心肌梗死(MI)和心衰(HF)是心肌梗死后的主要并发症。本文描述了当代心肌梗死后复发性心肌梗死和心衰的风险。方法6804例初步出院诊断为心肌梗死的患者在美国贝勒斯科特医院(Baylor Scott &;研究对象为白人健康医院(2015年1月至2021年12月)。评估患者特征、治疗和结果,包括心衰事件、复发性心肌梗死、全因死亡、全因和心血管再住院。出院后3个月采用里程碑式方法评估1年预后。结果中位年龄为69岁,男性59.7%,非st段抬高型心肌梗死76.7%,合并症包括高血压(89%)、血脂异常(87%)、2型糖尿病(48%)、慢性肾病(34%);17%有心肌梗死史,23%有心衰史;63%的患者接受了经皮/手术血管重建术。在具有里程碑意义的1年结局(N = 6210)中,413例(6.7%)患者死亡,1730例(27.9%)有全因住院,735例(11.8%)有心血管住院,234例(3.8%)有复发性心肌梗死。在没有HF病史的患者中,1160例(23.8%)发生了突发HF[射血分数(EF)和lt;分别为40%、41% - 49%和50%)。发生心衰的患者有较高的死亡和住院风险(P <;.001),与EF无关。2179例EF患者;50%的患者在指数住院期间没有流行HF或HF, 257例(11.8%)发生HF, 77例(3.5%)在1年内复发心肌梗死。结论:在当代心肌梗死后队列中,即使在EF正常且出院时无心衰的患者中,发生心衰的风险大于心肌梗死复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Heart Journal
European Heart Journal 医学-心血管系统
CiteScore
39.30
自引率
6.90%
发文量
3942
审稿时长
1 months
期刊介绍: The European Heart Journal is a renowned international journal that focuses on cardiovascular medicine. It is published weekly and is the official journal of the European Society of Cardiology. This peer-reviewed journal is committed to publishing high-quality clinical and scientific material pertaining to all aspects of cardiovascular medicine. It covers a diverse range of topics including research findings, technical evaluations, and reviews. Moreover, the journal serves as a platform for the exchange of information and discussions on various aspects of cardiovascular medicine, including educational matters. In addition to original papers on cardiovascular medicine and surgery, the European Heart Journal also presents reviews, clinical perspectives, ESC Guidelines, and editorial articles that highlight recent advancements in cardiology. Additionally, the journal actively encourages readers to share their thoughts and opinions through correspondence.
期刊最新文献
Exercise training for cardiovascular prevention in patients with cancer. Trientine for hypertrophic cardiomyopathy: a phase 2 trial. Intramyocardial lipoma: a contrast echocardiography pitfall. Gut microbe-generated metabolite trimethylamine N-oxide and risk of abdominal aortic aneurysm: a cohort study. Bodybuilders or bodybreakers: when bigger muscles mean bigger health risks.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1